#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Corneal neovascularisation Acute graft versus host disease Fibrosarcoma metastatic Bulbospinal muscular atrophy congenital Short stature homeobox gene mutation Hereditary optic atrophy IgA nephropathy B precursor type acute leukaemia Mantle cell lymphoma refractory Rhabdomyosarcoma Hepatoblastoma Pulmonary tuberculosis Dementia Hypoparathyroidism Hormone-dependent prostate cancer More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome Crigler-Najjar syndrome – Treatment Primary mediastinal large B-cell lymphoma – Treatment Bronchopulmonary dysplasia – Basic Information Haemophilia B without inhibitors – Diagnostics Mantle cell lymphoma stage IV – Basic Information Thrombotic thrombocytopenic purpura Urea cycle disorder – Life with Disease Brain stem glioma – Diagnostics Mitochondrial myopathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Feladilimab Cefalexin Ck-0045 Fezolinetant Sorafenib Camphor RO7837195 Regn7508 Tivozanib Dronedarone Platelet Concentrate Ht-29-A Eo2318 20-HYDROXYECDYSONE Osteodex ALKYLATING AGENTS Vigabatrin Bay 3018250 M2Rlab Human Serum Albumin 5% More therapies…

    Learn about Your Condition

    Oesophageal cancer metastatic Fallopian tube cancer Breast neoplasm Oesophageal food impaction Thyroidectomy Primary hypercholesterolaemia Combined immunodeficiency Intestinal ischaemia Tonsillitis Nodal osteoarthritis Hidradenitis Stargardt's disease Cholangitis sclerosing Bronchopulmonary aspergillosis Haemorrhoids More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Comparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate with ciprofloxacin for treating chemotherapy-induced fever in adult hematology patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin Sodium
    • Ciprofloxacin
    • Ciprofloxacin Hydrochloride
    France

  • Study of AZD2962 tablets alone and with other medications in patients with myelodysplastic syndromes and dysplastic chronic myelomonocytic leukemia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Chronic myelomonocytic leukaemia
    • Haematological malignancy
    Spain

  • Study of gilteritinib with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed FLT3-positive acute myeloid leukemia patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    Italy

  • Study of Reduced Cyclophosphamide Dose After Haploidentical Stem Cell Transplantation in Patients with Blood Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Cyclophosphamide
    France

  • Study on the Safety and Effectiveness of Budoprutug in Patients with Immune Thrombocytopenia

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • BUDOPRUTUG
    Bulgaria Greece Spain

  • Study on the Effects of Mitapivat on Brain Blood Flow and Oxygen Use in Patients with Sickle Cell Anemia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Mitapivat
    The Netherlands
Previous Page
1 … 39 40 41 42 43 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!